Exzeo Group, Inc. (XZO) AI Stock Analysis

NYSE: XZOAI research summary: business, growth, valuation, analysts, bull and bear case.

XZO AI stock analysis summary

AI Research

Exzeo Group, Inc. (XZO) is an insurance technology and operations provider operating as a subsidiary of HCI Group. The company expanded revenue to $217.0M in FY2025 with net income of $82.7M, supported by a net cash position of $130.1M as of June 30, 2026. However, quarterly earnings fell 1.4% year-over-year in the latest quarter ending June 30, 2026, and the stock is down 31.2% year-to-date.

Market cap
$1.50B
Revenue (TTM)
$230.4M
P/E
17.4x
1Y return
—
S&P 500 16.8%
Avg. target
$26.00
55.8% vs last close

Bull case

  • Revenue expanded at a 59.0% CAGR from FY2019 to FY2025, with net income reaching $82.7M in FY2025.
  • The balance sheet maintains low leverage with $130.1M in net cash and a debt-to-equity ratio of 0.02 as of June 30, 2026.
  • Trailing twelve-month operating margin stands at 51.7%, well above the US-listed Financial Services peer median of 37.7%.

Bear case

  • Quarterly revenue growth slowed to 6.9% in the quarter ended June 30, 2026, while quarterly earnings dropped 1.4% year-over-year.
  • The stock is down 31.2% year-to-date and trades at a price-to-sales multiple of 6.5x, more than double the peer median of 3.2x.
  • Short interest stands elevated, with short percent of float recorded at 17.2%.

What Exzeo does

Exzeo Group, Inc. provides turnkey insurance technology and operations solutions to insurance carriers and agents across the United States. Its primary offering is the Exzeo Platform, an Insurance-as-a-Service system that manages quoting, underwriting, policy management, claims, and reporting. The company also offers CasaClue for data repository management, Harmony for policy administration, AtlasViewer for mapping and data visualization, and Mercury for workflow routing. Additional tools include ClaimColony for claims management, the JustEZ inspection app, Exahub for centralized data, and ExzeoIQ for reporting. Founded in 2012 and based in Tampa, Florida, Exzeo is a subsidiary of HCI Group, Inc. and was formerly known as TypTap Insurance Group, Inc.

Growth and profitability

Exzeo experienced significant growth after FY2022, when it generated $45.6M in revenue and a net loss of $54.7M. By FY2023, revenue rose 93.6% to $88.3M with net income turning positive at $20.8M. Revenue further increased 51.6% to $133.9M in FY2024 and 62.0% to $217.0M in FY2025, reaching net income of $82.7M and an operating margin of 48.8%. Over the five years from FY2019 to FY2025, revenue achieved a compound annual growth rate of 59.0%. For the trailing twelve months, revenue reached $230.4M with an operating margin of 51.7%. For the quarter ended June 30, 2026, revenue increased 6.9% year-over-year, while quarterly earnings declined 1.4%.

XZO income statement →

Balance sheet and cash flow

As of June 30, 2026, Exzeo held $136.7M in cash and short-term investments against $6.6M in total debt, resulting in net cash of $130.1M. Shareholders' equity stood at $288.2M, with total assets of $385.8M, a current ratio of 1.85, and a debt-to-equity ratio of 0.02. In FY2025, the company produced $100.3M in operating cash flow and $97.5M in free cash flow. Capital allocation in FY2025 included $2.8M for capital expenditures and $1.5M directed toward share buybacks.

XZO balance sheet →

Valuation and performance

Exzeo trades at a trailing price-to-earnings ratio of 17.4x and an enterprise value to EBITDA ratio of 11.8x. In comparison, the median of its US-listed Financial Services peers is 12.1x for trailing P/E and 11.7x for EV to EBITDA. Its price-to-sales ratio of 6.5x is above the peer median of 3.2x. The stock closed at $16.69 on October 16, 2026, down 31.2% year-to-date and 2.7% above its 200-day average, while the S&P 500 returned 16.8% over the past year.

XZO key metrics →

What analysts expect

Wall Street coverage includes 2 Strong Buy ratings and 1 Buy rating, with no Hold or Sell recommendations. The mean price target is $26.00, representing a 55.8% upside compared to the last close of $16.69. For the fiscal year ending December 31, 2026, analysts estimate revenue of $225.0M and EPS of $1.00, implying 1.0% EPS growth. For the following fiscal year, 1 analyst projects revenue of $261.8M and EPS of $1.15. The company beat EPS estimates in 3 of the last 4 quarters, and its next earnings date is December 9, 2026.

XZO forecast and price target →

Key risks and what to watch

  • Concentration of ownership is high, with insiders holding 87.2% of the company's shares.
  • Revenue growth for the full year ending December 31, 2026 is projected to slow to $225.0M, compared to $230.4M reported over the trailing twelve months.
  • The business faced severe profitability swings in the past, including an operating margin of -82.7% and a net loss of $54.7M in FY2022.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this XZO AI stock analysis

This page is an AI-written research summary of Exzeo Group, Inc. (XZO). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: XZO income statement, XZO balance sheet, XZO key metrics, XZO analyst forecast, XZO chart. See the XZO stock overview for the latest quote and news.

XZO AI stock analysis FAQ

Who owns Exzeo Group, Inc.?

Exzeo Group, Inc. is a subsidiary of HCI Group, Inc. Insiders own 87.2% of the company's shares, while institutional investors hold 7.9%.

Does Exzeo Group pay a dividend?

No, Exzeo Group does not pay a dividend. In FY2025, the company deployed $1.5M toward share buybacks and $2.8M into capital expenditures.

What is Exzeo's cash and debt position?

As of June 30, 2026, Exzeo held $136.7M in cash and short-term investments and $6.6M in total debt, resulting in net cash of $130.1M.

What are analysts forecasting for XZO stock?

Analysts maintain a mean price target of $26.00, which is 55.8% above its closing price of $16.69 on October 16, 2026. For the year ending December 31, 2026, EPS is estimated at $1.00 on revenue of $225.0M.

More Financial Services AI stock analysis